Who We Are
BioCircuit Technologies is at the forefront of developing and commercializing advanced medical devices for tissue repair and neuromodulation.
Based in Atlanta, GA, BioCircuit Technologies is at the forefront of developing and commercializing advanced medical devices for tissue repair and neuromodulation. Our first commercial product, Nerve Tape®, is the first sutureless device for repairing transected nerves. This groundbreaking product enables fast, consistent, and precise nerve repairs, providing high-quality repairs while simplifying complex procedures for surgeons.
At BioCircuit, our expertise lies in biomaterials, precision nitinol design and manufacturing, and bioelectronics for nerve stimulation and recording. These strengths enable us to deliver innovative, high-performance solutions to the medical community. We are committed to expanding our portfolio with products that reflect our mission to provide simple, precise solutions that enhance surgical capabilities and improve patient care.
About Us
Our efforts are supported by significant small business funding from the National Institutes of Health (NIH NINDS R44NS097113 and SB1NS137879), as well as private investment from the GRA Venture Fund, Masters Capital, Alsora Capital, and other private investors.
These partnerships empower BioCircuit to drive innovation, bringing new, clinically valuable technologies from concept to practice.
Our board members bring a wealth of knowledge, industry experience, and visionary leadership to BioCircuit.